Sean Lee
Stock Analyst at HC Wainwright & Co.
(3.71)
# 699
Out of 4,873 analysts
84
Total ratings
28.92%
Success rate
15.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SENS Senseonics Holdings | Assumes: Buy | $1.1 | $0.50 | +121.64% | 1 | Jun 2, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.23 | +225.20% | 9 | May 19, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $1.27 | -21.26% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $4.62 | +203.03% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.76 | +110.08% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $10.86 | +84.16% | 12 | Apr 14, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $32.54 | +22.93% | 10 | Apr 1, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $8 → $5.5 | $0.18 | +2,884.26% | 11 | Mar 28, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $3.73 | +194.91% | 3 | Mar 26, 2025 | |
| MYO Myomo | Maintains: Buy | $7.5 → $9.5 | $2.27 | +318.50% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $6.77 | +1,377.10% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.16 | +2,486.21% | 1 | Dec 5, 2022 |
Senseonics Holdings
Jun 2, 2025
Assumes: Buy
Price Target: $1.1
Current: $0.50
Upside: +121.64%
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.23
Upside: +225.20%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $1.27
Upside: -21.26%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $4.62
Upside: +203.03%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.76
Upside: +110.08%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $10.86
Upside: +84.16%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $32.54
Upside: +22.93%
Plus Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $8 → $5.5
Current: $0.18
Upside: +2,884.26%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $3.73
Upside: +194.91%
Myomo
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $2.27
Upside: +318.50%
Jul 12, 2024
Reiterates: Buy
Price Target: $100
Current: $6.77
Upside: +1,377.10%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.16
Upside: +2,486.21%